Home » Topics » Dermatologic, BioWorld Science

Dermatologic, BioWorld Science
RSS

FDA clears use of Allergan's Tazorac cream for treatment of acne

Oct. 18, 2001

Gliatech obtains disappointing results from MRI reevaluation of ADCON-L

Oct. 17, 2001

Dapsone development for acne and burn itch progresses at Atrix

Oct. 16, 2001

Second phase I/II clinical trial of Levulan PDT begins for treatment of Barrett's esophagus

Oct. 11, 2001

FDA and EMEA accept Amevive filing for psoriasis

Oct. 11, 2001

Karo Bio updates KB-002611 clinical development

Oct. 10, 2001

New compounds designed at Welsh university inhibit retinoic acid metabolism

Oct. 5, 2001

Canadian trials of ISAtx-247 commence in psoriasis patients

Oct. 5, 2001

FDA approves Dermagraft living human dermal substitute

Oct. 4, 2001

Skin repair trial for sun damage set to begin with NV-07a

Oct. 2, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 30, 2026.
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 24, 2026